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Generalized severe epidermolysis bullosa simplex (GS-EBS) (formerly Dowling-Meara) is a 
rare autosomal dominant skin fragility disorder characterized by life-long herpetiform 
blistering and painful palmoplantar keratoderma (Fine et al., 2014). The disorder results 
from mutations in KRT5 or KRT14, encoding keratins 5 and 14, respectively, which impair the 
structural integrity of basal keratinocyte intermediate filaments.  GS-EBS is not usually 
associated with the serious morbidity and mortality of other generalized severe 
epidermolysis bullosa (EB) subtypes, particularly with respect to mucosal involvement, 
scarring and skin cancer. Nonetheless, some neonates are extremely ill and may not survive; 
the cumulative risk of death by age 1 year in GS-EBS is 2.8% (Fine et al., 2008). We sought to 
characterize individuals with GS-EBS who did not survive infancy. 
 
In the UK, the National Health Service (NHS) funds a unified service for EB. Specialist nurses 
visit all babies with suspected EB in England and Wales within a few days of birth. Diagnostic 
testing based on skin immunofluorescence, electron microscopy, and DNA analysis as well 
as lifelong expert care are routinely available at no cost to families. Severe cases in Scotland 
and Northern Ireland are also notified to the service. These arrangements ensure 
comprehensive case ascertainment. 
 
A review of all patients with GS-EBS born between January 2000 and October 2015 and 
notified to the EB service revealed 37 cases of which 5 died (Table 1). Four of these had no 
family history while one was born to an affected mother, and all five families originated 
from different countries. All deaths occurred within the first six months and there was a 
tendency to low birth-weight. All had extensive skin loss at birth and required intensive 
medical care, with parenteral feeding, opiate analgesia and antibiotics, until death.  
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Mutation analysis in 33 of these patients or their affected relatives showed KRT5 mutations 
in 17, KRT14  mutations in 15 and mutations in both KRT5 and KRT14 in one (Table 2). 
Remarkably, all 5 deceased patients had the same mutation in exon 7 of KRT5: c.1429G>A, 
p.Glu477Lys (E477K). Only three other patients with this mutation are known to us, all alive 
but severely affected. The first is a 4 year old girl born at 35.5 weeks, birth weight 2.86 kg 
(75
th
 centile) with extensive skin loss at birth and coincidental congenital hypothyroidism. 
Birmingham EB Severity (BEBS) score was 24.5 at 3 months; median (and range) for GS-EBS 
all ages = 6.3 (2.8-22.5) (Moss et al., 2009). The second, mother of deceased case 5, had 
severe blistering in childhood and now has marked palmoplantar keratoderma with 
significant pain and recurrent infections restricting mobility, and severe periodontal disease. 
The third, born at 39 weeks, weight 2.3kg (<2
nd
 centile) with extensive skin fragility and 
hoarseness had BEBS score 38 at day 20, and at day 40 remains an inpatient with feeding 
difficulties and recurrent skin infections.  
 
Coulombe and Lee (2012) reported more than twice as many cases of GS-EBS caused by 
KRT14 compared with KRT5 mutations, attributing this excess to a high frequency of 
mutations at codon 125 of KRT14. This hotspot codon of KRT14 and other type I keratins 
probably reflects deamination of methylated cytosine in a CpG dinucleotide, this being the 
most frequent mechanism for mutations in the human genome. We found a more equal 
ratio (16:18) despite 6 of our 16 KRT14 cases showing mutations in codon 125. 
 
Regarding genotype-phenotype correlation, GS-EBS is caused by KRT5 and KRT14 mutations 
in the highly conserved ends of the alpha-helical rod domain, the helix boundary motifs 
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(HBMs), while mutations outside the HBMs are associated with milder EBS phenotypes. 
Clinical severity also depends on the nature of the amino acid change. For example, 
p.Glu477Gly in KRT5 results in localized EBS whilst p.Glu477Lys, p.Glu477Asp and p.Glu477X 
all cause GS-EBS (http://www.interfil.org/ accessed 11 October 2015). An amino acid 
substitution which changes polarity or acidity of the protein can be expected to cause a 
more severe phenotype; in particular, the substitution of an acidic glutamate with a basic 
lysine residue in the p.Glu477Lys mutation alters the second glutamate residue of the 
KLLEGE motif, which is the most evolutionarily conserved motif among all types of 
intermediate filament proteins (Stephens et al., 1997) and severely disrupts basal keratin 
intermediate filaments. Letai et al. (1992) postulated that KRT5 p.Glu477Lys is a potentially 
lethal mutation.  There are at least 10 reported cases of GS-EBS with this KRT5 mutation 
(Supplementary Table S1) but clinical information is limited and mortality data is not 
reported. Survivors will be over-represented if, as seems likely, some affected neonates die 
before genetic studies can be done, and the mutation is de novo.  
 
All reported cases, and all but one of ours, were sporadic, consistent with a recurrent “hot-
spot” mutation due to spontaneous deamination of a methylated cytosine in a CpG 
dinucleotide. 
 
Death in infants with GS-EBS has been attributed to infection and respiratory failure (Fine et 
al., 2008) but it is unclear what makes these infants so susceptible. Evidence from animal 
studies suggests that KRT5 mutations are more damaging than KRT14 mutations, with 
effects extending beyond skin fragility (Coulombe and Lee, 2012). Krt5-null mice show 
markedly more severe skin and oesophageal involvement and earlier death than Krt14-null 
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mice, the latter possibly being protected by upregulation of Krt15 and Krt16 which are 
homologous to and can compensate for Krt14. The same explanation may hold in human 
patients, since human “KRT5 knockouts” have not been reported whilst “KRT14 knockouts” 
can be relatively mildly affected (Coulombe and Lee, 2012). Increased inflammatory 
cytokines in the epidermis of Krt5 null mice (Peters et al., 2001) and increased density of 
Langerhans cells in both Krt5-null mice and in patients with EBS due to KRT5 mutations 
(Roth et al, 2009) implicate keratin 5 as an immune modulator in the skin.  
 
These preliminary findings add to our understanding of genotype-phenotype correlation in 
GS-EBS; they suggest that the KRT5 p.Glu477Lys mutation may predispose to a severe and 
potentially lethal variant of GS-EBS which should inform prognostication in this cohort of 
patients. 
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Table 1. Infants from the GS-EBS cohort who died, all with KRT5 p.Glu477Gly mutation 
 
No Sex Ethnicity or 
Parental origin 
Age at 
death 
(days) 
Gestational 
age 
Mode of 
delivery 
Birth 
wt in 
kg 
Birth 
weight 
centile 
Family 
history 
1. M N Europe/ 
S America 
8 38 CS 3.5 75
th
  Nil 
2 F Afghanisthan 57 34+3 NVD 1.59 2-9
th
  Nil 
3 M Nigeria 170 Term CS 2.57 <25
th
  Nil 
4 M Pakistan 15 39+3 NVD 2.32 0.4
th
 Nil 
5 F Irish 53 37+5 CS 2.4  9
th
  Mother 
affected 
 
Additional medical problems: case 1 - severe gastro-esophageal reflux, stridor and 
hoarseness with episodes of cyanosis; case 2 - subtle dysmorphism, neurological problems, 
poor weight gain, anemia, and septicemia; case 3 - gastro-esophageal reflux, severe 
malnutrition and infections of central line and skin with enterococcus and pseudomonas, 
respectively; case 4 - necrotizing enterocolitis with septicemia, thrombocytopenia and renal 
failure; case 5 - feeding difficulties and Group B streptococcal infection. 
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Table 2. All mutations found in the GS-EBS cohort (unavailable in 4 of 37 patients) 
 
* Deceased 
 Gene Mutation 
1.  KRT14 p.Arg125Cys 
2.  KRT14 p.Arg125Cys 
3.  KRT14 p.Arg125His 
4.  KRT14 p.Arg125His 
5.  KRT14 p.Arg125His 
6.  KRT14 p.Arg125His 
7.  KRT14 p.Asn123Ser 
8.  KRT14 p.Asn123Ser 
9.  KRT14 p.Asp123Lys 
10.  KRT14 p.Glu420X 
11.  KRT14 p.Glu478Lys 
12.  KRT14 p.Leu122Phe 
13.  KRT14 p.Leu122Phe 
14.  KRT14 p.Ser128del 
15.  KRT14 p.Tyr129Asp 
16.  KRT14/KRT5 p.Arg125His 
p.Arg471Cys 
17.  KRT5 p.Ala428Asp 
18.  KRT5 p.Glu168Gly 
19.  KRT5 p.Glu475Gly 
20.  KRT5 p.Glu475Gly 
21. * KRT5 p.Glu477Lys 
22. * KRT5 p.Glu477Lys 
23. * KRT5 p.Glu477Lys 
24. * KRT5 p.Glu477Lys 
25. * KRT5 p.Glu477Lys 
26.  KRT5 p.Glu477Lys 
27.  KRT5 p.Glu477Lys 
28.  KRT5 p.Leu175Arg 
29.  KRT5 p.Leu175Phe 
30.  KRT5 p.Leu202Pro 
31.  KRT5 p.Leu473Gln 
32.  KRT5 p.Phe179Ser 
33.  KRT5 p.Val145Asp 
 
  
